NMPA Approval

Buprenorphine Hydrochloride Sublingual Tablets

Approval Number

国药准字H10970125

Company天津药物研究院药业有限责任公司

Registration Date

March 27, 2020

Drug Information

Generic Name

盐酸丁丙诺啡舌下片

Trade Name

沙菲

Dosage Form

片剂

Strength

0.4mg

Drug Type

化学药品

Registration Date

March 27, 2020

Company Information

Applicant Company

Company Name天津药物研究院药业有限责任公司

Manufacturing Company

Company Name天津药物研究院药业有限责任公司

Company Address

天津滨海高新区滨海科技园惠新路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸丁丙诺啡舌下片 - NMPA 批准文号 | MedPath